ClinicalTrials.Veeva

Menu

Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer

C

Chulalongkorn University

Status

Unknown

Conditions

Health, Subjective

Treatments

Dietary Supplement: undenatured collagen type II (UCII) supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT05002634
EC2104220

Details and patient eligibility

About

This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.

Full description

This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months. Liver function test, renal function test, and adverse event will be assessed before and after taking for 1 and 2 months.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 20-60 years
  • No taking collagen supplement more than 2 weeks
  • No collagen and protein allergy
  • No liver and renal disease
  • Have a willingness to participate in the study

Exclusion criteria

  • Uncontrolled disease
  • Have complication symptom during study
  • Pregnancy or lactation
  • Cannot follow the protocol
  • During participated in other studies

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

undenatured collagen type II (UCII) supplement
Experimental group
Description:
The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months.
Treatment:
Dietary Supplement: undenatured collagen type II (UCII) supplement

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems